8th Annual Dermatology Drug Development Summit

November 12-14, 2024
Boston, MA

The 8th Dermatology Drug Development Summit serves as a pivotal platform for advancing therapies in immuno-inflammatory skin diseases, amid a competitive landscape underscored by significant industry developments and clinical successes from Galderma, Incyte, and Eli Lilly. The summit focuses on addressing the high unmet medical need posed by disease heterogeneity, highlighting advancements and challenges in drug development. Key topics include workshops on Hidradenitis Suppurativa and JAK inhibitors, exploration of multipurpose drug strategies across dermatology and beyond, discussions on patient recruitment strategies in rare diseases, and insights into cutting-edge R&D and commercialization strategies.

The summit features comprehensive discussions on clinical trial design, efficacy endpoints, and regulatory considerations, aimed at enhancing understanding and implementation strategies across dermatological therapies. PRC Clinical specializes in providing tailored solutions to enable biotech and pharmaceutical companies to navigate dermatological research with confidence and efficiency, from site management and patient recruitment strategies to regulatory compliance and data management. Fill out the form below to connect with the PRC team virtually or at an upcoming industry event such as this.

View the Conference Website